Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q2 2023 Earnings Call Transcript August 10, 2023
Panbela Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.00795 EPS, expectations were $4.71.
Operator: Greetings and welcome to the Panbela Therapeutics Second Quarter 2023 Earnings Call. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to your host, James Carbonara, Investor Relations at Panbela. James, you may...
